{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:30:18Z","timestamp":1784903418925,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Research and development program of North Sichuan Medical College","award":["CBY23-TD01"],"award-info":[{"award-number":["CBY23-TD01"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Nanchong science and technology plan project","award":["23JCYJPT0059"],"award-info":[{"award-number":["23JCYJPT0059"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Medical Science and Technology Innovation Research Society Program","award":["YCH-KY-YCZD2024-015"],"award-info":[{"award-number":["YCH-KY-YCZD2024-015"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]},{"name":"Sichuan Province Clinical Key Specialty Construction Project","award":["2023GZZKP002"],"award-info":[{"award-number":["2023GZZKP002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and purpose<\/jats:title>\n            <jats:p>Research shows that people with multiple sclerosis (MS) are more likely to experience cardiovascular complications. However, the precise mechanisms underlying this association remain unclear. This study investigated the causal relationship between MS and coronary heart disease (CHD) using Mendelian randomization (MR) techniques to clarify direct effects and identify relevant target genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted various methods, including two-sample MR. method, reverse, and multivariable MR analyses, to examine the causal relationship between MS and CHD. These. methodologies effectively mitigate confounding variables and neutralize adverse causal effects. Additionally, the study explored the involvement of social factors through a two-step MR analysis. The research team performed a thorough screening of differentially expressed genes in MS based on GEO database, identifying potential target genes that may be associated with genetic risk of CHD. Enrichment analyses and protein-protein interaction studies were used to elucidate biological functions associated with these genes. We included colocalization analysis and summary data-based Mendelian randomization (SMR) method for further screening of core genes to obtain target genes.Finally, we investigated how these genes might affect health by conducting a phenome-wide MR analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our findings revealed that genetic predisposition to MS significantly increases the risk of CHD, with an IVW-MR analysis yielding an odds ratio of 1.091 (95% CI: 1.030, 1.155, <jats:italic>P<\/jats:italic>\u2009=\u20090.0029). Mediation analysis revealed that frailty mediated 20.2% of the effect of MS on CHD (<jats:italic>P<\/jats:italic>\u2009=\u20090.026), suggesting that frailty is a critical pathway in this relationship. Additionally, low-density lipoprotein (LDL) is associated with an increased risk of developing both MS and CHD. We identified 3025 differentially expressed genes and 130 genes causally linked to CHD. Protein-protein interaction network analysis identified 77 interacting genes, with core genes such as SREBF1 involved in organelle regulation and nucleic acid metabolism. Colocalization analysis further supported the presence of shared genetic variants between IL6R and SREBF1 associated with CHD, with posterior probabilities (PPH4) of 90.2% and 92.3%, respectively. Interestingly, summary mendelian randomization (SMR) analysis revealed that SREBF1 may be a target gene for MS(bSMR=-0.174,PSMR\u2009=\u20090.0218, PHEIDI\u2009=\u20090.2806, topSNP: rs12951376). Further analysis of the phenome-wide MR did not find significant evidence of side effect associated with targeted therapy against SREBF1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study provided genetic evidence indicating that indivduals with MS face higher risk of coronary heart disease. Furthermore, SREBF1 maybe a critical target gene which would significantly contribute to drug development.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00388-6","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:25:53Z","timestamp":1739521553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SREBF1, a target gene of multiple sclerosis and coronary heart disease: based on mendelian randomization study"],"prefix":"10.1186","volume":"162","author":[{"given":"Linqin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofe Eugene","family":"Kwaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7239-3534","authenticated-orcid":false,"given":"Rongchuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"25","key":"388_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990\u20132019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"388_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr, Tabas I, et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389\u2013406. https:\/\/doi.org\/10.1038\/s41569-019-0169-2.","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"388_CR3","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms232112906","volume":"23","author":"MY Henein","year":"2022","unstructured":"Henein MY, Vancheri S, Longo G, et al. The role of inflammation in cardiovascular disease. Int J Mol Sci. 2022;23(21):12906. https:\/\/doi.org\/10.3390\/ijms232112906.","journal-title":"Int J Mol Sci"},{"key":"388_CR4","doi-asserted-by":"publisher","first-page":"1038738","DOI":"10.3389\/fcvm20231038738","volume":"10","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ji C, Zhai X, et al. Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: a bibliometric analysis of 1990\u20132022. Front Cardiovasc Med. 2023;10:1038738. https:\/\/doi.org\/10.3389\/fcvm20231038738.","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"388_CR5","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R. What Is Multiple Sclerosis? JAMA. 2022;328(20):2078. https:\/\/doi.org\/10.1001\/jama.2022.14236.","journal-title":"JAMA"},{"issue":"5","key":"388_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"Global Burden of Disease Study 2016","year":"2019","unstructured":"Global Burden of Disease Study 2016. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","journal-title":"Lancet Neurol"},{"key":"388_CR7","doi-asserted-by":"publisher","first-page":"100977","DOI":"10.1016\/j.lanepe.2024.100977","volume":"44","author":"E Portaccio.","year":"2024","unstructured":"Portaccio. E, Magyari. M, Havrdova EK, et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur. 2024;44:100977. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100977.","journal-title":"Lancet Reg Health Eur"},{"issue":"10","key":"388_CR8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/1352458513475833","volume":"19","author":"E Jadidi","year":"2013","unstructured":"Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler. 2013;19(10):1336\u201340. https:\/\/doi.org\/10.1177\/1352458513475833.","journal-title":"Mult Scler"},{"key":"388_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1001\/jamaneurol.2020.0664","volume":"7","author":"R Palladino","year":"2020","unstructured":"Palladino R, Marrie RA, Majeed A, et al. Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England. JAMA Neurol. 2020;7:820\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0664.","journal-title":"JAMA Neurol"},{"issue":"14","key":"388_CR10","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1177\/1352458516635873","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Bos SD, Harbo HF, et al. Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors. Mult Scler. 2016;22(14):1783\u201393. https:\/\/doi.org\/10.1177\/1352458516635873.","journal-title":"Mult Scler"},{"key":"388_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","volume":"4","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, et al. The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects. Inflammopharmacology. 2023;4:1671\u201382. https:\/\/doi.org\/10.1007\/s10787-023-01240-x.","journal-title":"Inflammopharmacology"},{"issue":"9936","key":"388_CR12","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","volume":"383","author":"J Chataway","year":"2014","unstructured":"Chataway J, Schuerer N, Alsanousi A, et al. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet (London England). 2014;383(9936):2213\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(13)62242-4.","journal-title":"Lancet (London England)"},{"key":"388_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"8","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;8:1133\u201363. https:\/\/doi.org\/10.1002\/sim.3034.","journal-title":"Stat Med"},{"key":"388_CR14","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"11","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del,Greco MF, Pattaro C, et al. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrol. 2016;11:3253\u201365. https:\/\/doi.org\/10.1681\/ASN.2016010098.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"388_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ije\/dyv071","volume":"44","author":"AG Boef","year":"2015","unstructured":"Boef AG, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2):496\u2013511. https:\/\/doi.org\/10.1093\/ije\/dyv071.","journal-title":"Int J Epidemiol"},{"issue":"7359","key":"388_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214\u20139. https:\/\/doi.org\/10.1038\/nature10251.","journal-title":"Nature."},{"issue":"11","key":"388_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ng.2770","volume":"45","author":"AH Beecham","year":"2013","unstructured":"International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45(11):1353\u201360. https:\/\/doi.org\/10.1038\/ng.2770.","journal-title":"Nat Genet"},{"issue":"4","key":"388_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, K\u00f6nig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333\u20138. https:\/\/doi.org\/10.1038\/ng.784.","journal-title":"Nat Genet"},{"issue":"7","key":"388_CR19","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","volume":"7","author":"T Schoeler","year":"2023","unstructured":"Schoeler T, Speed D, Porcu E, et al. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7(7):1216\u201327. https:\/\/doi.org\/10.1038\/s41562-023-01579-9.","journal-title":"Nat Hum Behav"},{"key":"388_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fgene.2020.00157","volume":"11","author":"TA Myers","year":"2020","unstructured":"Myers TA, Chanock SJ, Machiela MJ. LDlinkR: an R Package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020;11:11. https:\/\/doi.org\/10.3389\/fgene.2020.00157.","journal-title":"Front Genet."},{"issue":"16","key":"388_CR21","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-20-0985","volume":"80","author":"SH Lin","year":"2020","unstructured":"Lin SH, Brown DW, Machiela MJ. LDtrait: an Online Tool for identifying published phenotype associations in linkage disequilibrium. Cancer Res. 2020;80(16):3443\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0985.","journal-title":"Cancer Res"},{"issue":"11","key":"388_CR22","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journalpgen1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G, et al. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. https:\/\/doi.org\/10.1371\/journalpgen1007081.","journal-title":"PLoS Genet"},{"issue":"3","key":"388_CR23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden J, Del Greco M, Minelli F, et al. Improving the accuracy of two-sample summary-data mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48(3):728\u201342. https:\/\/doi.org\/10.1093\/ije\/dyy258.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"388_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, et al. Using published data in mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015;30(7):543\u201352. https:\/\/doi.org\/10.1007\/s10654-015-0011-z.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"388_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S, et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"388_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"388_CR27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","volume":"36","author":"J Zhao","year":"2020","unstructured":"Zhao J, Ming J, Hu X, et al. Bayesian weighted mendelian randomization for causal inference based on summary statistics. Bioinf (Oxford England). 2020;36(5):1501\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btz749.","journal-title":"Bioinf (Oxford England)"},{"issue":"1","key":"388_CR28","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1093\/brain\/awad295","volume":"147","author":"Q Yin","year":"2024","unstructured":"Yin Q, Zhu L. Does co-localization analysis reinforce the results of mendelian randomization? Brain. 2024;147(1):e7\u20138. https:\/\/doi.org\/10.1093\/brain\/awad295.","journal-title":"Brain"},{"issue":"26","key":"388_CR29","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1002\/sim.9156","volume":"40","author":"AJ Grant","year":"2021","unstructured":"Grant AJ, Burgess S. Pleiotropy robust methods for multivariable mendelian randomization. Stat Med. 2021;40(26):5813\u201330. https:\/\/doi.org\/10.1002\/sim.9156.","journal-title":"Stat Med"},{"issue":"3","key":"388_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ije\/dyy262","volume":"48","author":"E Sanderson","year":"2019","unstructured":"Sanderson E, Davey Smith G, Windmeijer F, et al. An examination of multivariable mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2019;48(3):713\u201327. https:\/\/doi.org\/10.1093\/ije\/dyy262.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"388_CR31","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/ije\/dyad090","volume":"52","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lai H, Zhang R, et al. Causal relationship between gastro-esophageal reflux disease and risk of lung cancer: insights from multivariable mendelian randomization and mediation analysis. Int J Epidemiol. 2023;52(5):1435\u201347. https:\/\/doi.org\/10.1093\/ije\/dyad090.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"388_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465\u201378. https:\/\/doi.org\/10.1007\/s10654-021-00757-1.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"388_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"issue":"7","key":"388_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"issue":"Database Issue","key":"388_CR35","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database Issue):D991\u20135. https:\/\/doi.org\/10.1093\/nar\/gks1193.","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"388_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jneuroim.2012.05.013","volume":"250","author":"LL Aung","year":"2012","unstructured":"Aung LL, Brooks A, Greenberg SA, et al. Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells. J Neuroimmunol. 2012;250(1\u20132):99\u2013105. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.05.013.","journal-title":"J Neuroimmunol"},{"key":"388_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.nbd.2022.105953","volume":"176","author":"E Shavit","year":"2023","unstructured":"Shavit E, Menascu S, Achiron A, et al. Age-related blood transcriptional regulators affect disease progression in pediatric multiple sclerosis. Neurobiol Dis. 2023;176:176. https:\/\/doi.org\/10.1016\/j.nbd.2022.105953.","journal-title":"Neurobiol Dis."},{"issue":"9","key":"388_CR38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"key":"388_CR39","doi-asserted-by":"publisher","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science (New York, N.Y.). 2020;369(6509):1318\u20131330. https:\/\/doi.org\/10.1126\/science.aaz1776","DOI":"10.1126\/science.aaz1776"},{"issue":"10","key":"388_CR40","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.2756","volume":"45","author":"HJ Westra","year":"2013","unstructured":"Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45(10):1238\u201343. https:\/\/doi.org\/10.1038\/ng.2756.","journal-title":"Nat Genet"},{"issue":"D1","key":"388_CR41","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"388_CR42","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Cambridge (Mass)). 2021;2(3):100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innov (Cambridge (Mass))"},{"issue":"11","key":"388_CR43","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journalpone0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE. 2023;18(11):e0294236. https:\/\/doi.org\/10.1371\/journalpone0294236.","journal-title":"PLoS ONE"},{"issue":"5","key":"388_CR44","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5): e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","journal-title":"PLoS Genet"},{"issue":"1","key":"388_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si S, Liu H, Xu L, et al. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 2024;16(1):84. https:\/\/doi.org\/10.1186\/s13073-024-01356-x.","journal-title":"Genome Med"},{"issue":"5","key":"388_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"issue":"1","key":"388_CR47","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F, et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nature communications. 2018;9(1):918. https:\/\/doi.org\/10.1038\/s41467-018-03371-0.","journal-title":"Nature communications"},{"key":"388_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2023.1197195","volume":"14","author":"RA Marrie","year":"2023","unstructured":"Marrie RA, Fisk JD, Fitzgerald K, et al. Etiology, effects and management of comorbidities in multiple sclerosis: recent advances. Front Immunol. 2023;14:14. https:\/\/doi.org\/10.3389\/fimmu.2023.1197195.","journal-title":"Front Immunol."},{"issue":"10354","key":"388_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet (London England). 2022;400(10354):733\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6.","journal-title":"Lancet (London England)"},{"key":"388_CR50","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;381:752\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(12)62167-9.","journal-title":"Lancet"},{"issue":"15","key":"388_CR51","doi-asserted-by":"publisher","first-page":"e031736","DOI":"10.1161\/JAHA.123.031736","volume":"13","author":"K James","year":"2024","unstructured":"James K, Jamil Y, Kumar M, et al. Frailty and Cardiovascular Health. J Am Heart Association. 2024;13(15):e031736. https:\/\/doi.org\/10.1161\/JAHA.123.031736.","journal-title":"J Am Heart Association"},{"issue":"12","key":"388_CR52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehad885.","journal-title":"Eur Heart J"},{"key":"388_CR53","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","volume":"7","author":"P Hanlon","year":"2018","unstructured":"Hanlon P, Nicholl BI, Jani BD, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;7:e323\u201332. https:\/\/doi.org\/10.1016\/S2468-2667(18)30091-4.","journal-title":"Lancet Public Health"},{"issue":"1","key":"388_CR54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","volume":"75","author":"C Yokoyama","year":"1993","unstructured":"Yokoyama C, Wang X, Briggs MR, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75(1):187\u201397.","journal-title":"Cell"},{"key":"388_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0092-8674(00)80213-5","volume":"3","author":"MS Brown","year":"1997","unstructured":"Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;3:331\u201340. https:\/\/doi.org\/10.1016\/s0092-8674(00)80213-5.","journal-title":"Cell."},{"key":"388_CR56","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/15548627.2023.2275501","volume":"5","author":"F Geng","year":"2024","unstructured":"Geng F, Guo D. SREBF1\/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth. Autophagy. 2024;5:1183\u20135. https:\/\/doi.org\/10.1080\/15548627.2023.2275501.","journal-title":"Autophagy"},{"key":"388_CR57","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","volume":"87","author":"MS Brown","year":"2018","unstructured":"Brown MS, Radhakrishnan A, Goldstein JL. Retrospective on cholesterol homeostasis: the Central Role of Scap. Annu Rev Biochem. 2018;87:783\u2013807. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-011852.","journal-title":"Annu Rev Biochem."},{"issue":"6","key":"388_CR58","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/1568026618666180523104541","volume":"18","author":"X Cheng","year":"2018","unstructured":"Cheng X, Li J, Guo D. SCAP\/SREBPs are central players in lipid metabolism and novel metabolic targets in Cancer Therapy. Curr Top Med Chem. 2018;18(6):484\u201393. https:\/\/doi.org\/10.2174\/1568026618666180523104541.","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"388_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2990.1994.tb01174.x","volume":"20","author":"J Newcombe","year":"1994","unstructured":"Newcombe J, Li H, Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol. 1994;20(2):152\u201362. https:\/\/doi.org\/10.1111\/j.1365-2990.1994.tb01174.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"388_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.msard.2015.10.005","volume":"5","author":"S Zhornitsky","year":"2016","unstructured":"Zhornitsky S, McKay KA, Metz LM, et al. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53\u201365. https:\/\/doi.org\/10.1016\/j.msard.2015.10.005.","journal-title":"Mult Scler Relat Disord."},{"key":"388_CR61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.redox.2012.12.001","volume":"1","author":"G Poli","year":"2013","unstructured":"Poli G, Biasi F, Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 2013;1:125\u201330. https:\/\/doi.org\/10.1016\/j.redox.2012.12.001.","journal-title":"Redox Biol."},{"issue":"5","key":"388_CR62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ni.2570","volume":"14","author":"Y Kidani","year":"2013","unstructured":"Kidani Y, Elsaesser H, Hock MB, et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol. 2013;14(5):489\u201399. https:\/\/doi.org\/10.1038\/ni.2570.","journal-title":"Nat Immunol"},{"key":"388_CR63","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.cell.2017.09.029","volume":"5","author":"EV Dang","year":"2017","unstructured":"Dang EV, McDonald JG, Russell DW, et al. Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation. Cell. 2017;5:1057\u20131071.e11. https:\/\/doi.org\/10.1016\/j.cell.2017.09.029.","journal-title":"Cell."},{"key":"388_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2024.1398921","volume":"15","author":"X Xu","year":"2024","unstructured":"Xu X, Jin W, Chang R, et al. Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases. Front Immunol. 2024;15:15. https:\/\/doi.org\/10.3389\/fimmu.2024.1398921.","journal-title":"Front Immunol."},{"issue":"7845","key":"388_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590(7845):290\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03205-y.","journal-title":"Nature"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00388-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00388-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T20:05:33Z","timestamp":1739563533000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00388-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00388-6","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}